
Overview
Financials
Revenue history (in m)
From the notes
| Current income tax (CIT due) | $40,904 | |
| Profit allocation | Retained in reserve capital | |
| Capital expenditure | $1,120 | |
| Planned capital expenditure (next year) | $12,557 | |
| Receivables write-downs | $22,356 | |
| Management board pay | $8,287 |
Filing timeliness
1 of 6 financial statements was filed late (for 2021, 11 days late). All were audited by a statutory auditor.
- 202507/07/2026
- 202407/07/2025
- 202308/07/2024
- 202204/07/2023
- 202126/07/2022
- 202025/06/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
Industry
Websites
The site is available in: Polish, English and Ukrainian. The site targets these markets: United States and Ukraine.
- biofarm.plBiofarm | Producent leków, firma farmaceutyczna z PoznaniaGoogle AnalyticsGoogle Tag ManagerApache
Public procurement
No recorded participation in tenders.
The company is the contractor in 2 public sector contracts, worth USD 776.47 in total. All of them were signed with the same public buyer.
| Signed on | Subject | Amount | Public buyer | |
|---|---|---|---|---|
| Oct 2, 2026 | Purchase and delivery of medicines | $579.44 | Samodzielny Publiczny Zakład Opieki Zdrowotnej Ministerstwa Spraw Wewnętrznych I Administracji w Koszalinie | |
| Aug 17, 2026 | Purchase and delivery of medicines | $197.03 | Samodzielny Publiczny Zakład Opieki Zdrowotnej Ministerstwa Spraw Wewnętrznych I Administracji w Koszalinie |
Job offers
The company has its own careers page: biofarm.pl/kariera.
Authorized Representatives
Manner of representation
With a multi-member management board: two members of the management board, or one member of the management board jointly with a commercial proxy.
Supervisory board
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
| 3,218 | $86,925.99 | 99.9689% | |
Others | 1 | $27.01 | 0.0311% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2003-12-31.
64 1240 1747 1111 0000 1849 0271
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| NGK Pharma sp. z o.o. | $23,065,140.55 | ngkpharma.pl | ||
| UNIT Dose Pharma sp. z o.o. | $13,712,927.12 | udpharma.pl | ||
| Przedsiębiorstwo Zaopatrzenia Farmaceutycznego Cefarm-Kielce S.A. | $13,590,657.96 | farmacol.com.pl | ||
| Orion Pharma Poland sp. z o.o. | $13,123,658.19 | orionpharma.pl | ||
| Hurtownia Farmaceutyczna Medifarm sp. z o.o. | $12,324,203.98 | medifarm.pl | ||
| Interpharma sp. z o.o. | $12,321,125.25 | interpharma.com.pl | ||
| Medinn sp. z o.o. | $11,689,415.29 | med-inn.pl | ||
| Trumedico Pl sp. z o.o. + limited partnership | $11,405,243.37 | trumedico.pl | ||
| Vipado sp. z o.o. | $11,385,128.54 | vipado.pl | ||
| Hurtownia Farmaceutyczna Solinea sp. z o.o. | $2,622,347.04 | solinea.pl |
Change history
| Date | Event | |
|---|---|---|
| 2009-08-10 | Name change (Biofarm - Hurt Spółka Z Ograniczoną Odpowiedzialnością W Likwidacji → Biofarm - Hurt) | |
| 2009-06-30 | Liquidation ended / withdrawn | |
| 2007-08-28 | Name change (Biofarm - Hurt → Biofarm - Hurt Spółka Z Ograniczoną Odpowiedzialnością W Likwidacji) | |
| 2007-08-01 | Liquidation opened | |
| 2001-10-04 | Share capital increase (221,900.00 PLN → 321,900.00 PLN) |
FAQ
Last updated: 2026-11-12